• USP Standard API Piroxicam Raw Material Powder Piroxicam CAS36322-90-4
  • USP Standard API Piroxicam Raw Material Powder Piroxicam CAS36322-90-4
  • USP Standard API Piroxicam Raw Material Powder Piroxicam CAS36322-90-4
  • USP Standard API Piroxicam Raw Material Powder Piroxicam CAS36322-90-4
  • USP Standard API Piroxicam Raw Material Powder Piroxicam CAS36322-90-4
  • USP Standard API Piroxicam Raw Material Powder Piroxicam CAS36322-90-4

USP Standard API Piroxicam Raw Material Powder Piroxicam CAS36322-90-4

Powder: Yes
Customized: Customized
Certification: GMP, ISO 9001, USP, BP
Suitable for: Elderly, Adult
State: Powder
Purity: >98%
Samples:
US$ 10/grams 1 grams(Min.Order)
| Request Sample
Customization:
Diamond Member Since 2019

Suppliers with verified business licenses

Rating: 4.9/5

Basic Info.

Model NO.
TGY201904150704
Appearance
Pale Yellow Powder
Molecular Formula
C15h13n3o4s
MW
331.35
Certificate
ISO 9001, USP
Shelf Life
24 Months
Storage
Cool Dry Area
Grade
Pharmaceutical Grade
CAS No.
36322-90-4
Sample
Avaliable
Service
OEM
MOQ
10 Grams
Assay
HPLC 99%
Test Method
USP
Einecs No.
252-974-3
Product Name
USP Standard API Piroxicam Raw Material Powder PIR
Transport Package
Boil Bag
Specification
HPLC 99%
Trademark
TGY
Origin
Xi′an, Shaanxi, China (Mainland)
HS Code
1534706968
Production Capacity
3000kg/Month

Product Description

USP Standard API Piroxicam Raw Material Powder Piroxicam CAS36322-90-4USP Standard API Piroxicam Raw Material Powder Piroxicam CAS36322-90-4

 

Product Name
 
Piroxicam

Alias
 
Piroxicam, Feldene; Piroxicamum; Pyroxycam; Roxicam

CAS
 
36322-90-4

MF
 
C15H13N3O4S

MW
 
331.35

Purity
 
98%

Grade
 
Pharmaceutical Grade

Appearance
 
Pale Yellow powder




Piroxicam is a nonsteroidal oxicam derivative with anti-inflammatory, antipyretic, and analgesic properties. As a
non-selective, nonsteroidal anti-inflammatory drug (NSAID), piroxicambinds and chelates are both isoforms of
cyclooxygenases (COX1 and COX2), thereby stalling phospholipase A2 activity and conversion of arachidonic
acid into prostaglandin precursors at the rate-limiting cyclooxygenase enzyme step. This results in inhibition of
prostaglandin biosynthesis. As a second, independent effect, piroxicam inhibits the activation of neutrophils
thereby contributing to its overall anti-inflammatory effects.


COA of Piroxicam Powder
 


Product name
 
Piroxicam
CAS No. 36322-90-4 Outer Packing 25KG /drum
Production date 2018.05.15 Shelf life 2020.05.14
Standard adopted USP39
Items of analysis Specification Results
Characteristics A white or slightly yellow, crystalline powder slightly yellow, crystalline powder
Water ≤0.5% 0.002%
Residue on ignition ≤0.3% 0.05%
Heavy metals ≤0.005% <0.005%
Organic volatile impurities Conforms to U.S.P39 Meet the requirements
Solubility very slightly soluble in water, in dilute acids, and in most organics solvents slightly soluble in alcohol and aqueous alkaline solutions Meet the requirements
residual resolver alcohol Meet the requirements
Assay 97-103% 99.7%
Conclusion Qualified


USP Standard API Piroxicam Raw Material Powder Piroxicam CAS36322-90-4

Piroxicam works by preventing the production of a certain type of body chemical called prostaglandins which are
involved in the mediation of pain, stiffness, tenderness, and swelling. The medicine is available as capsules, tablets, and (not in all countries) as a prescription-free gel 0.5%. It is also available in a beta dx formulation, which allows
more rapid absorption of piroxicam from the digestive tract.


Piroxicam is a nonsteroidal anti-inflammatory drug (NSAID) that is effective in treating fever, pain, and
inflammation in the body. Piroxicam is used for the treatment of inflammation and pain caused by rheumatoid
arthritis or osteoarthritis.


Dosage of Piroxicam Powder

The recommended dose is 20 mg once daily or 10 mg twice daily. Piroxicam should be taken with food.


Side Effect of Piroxicam Powder

The most common side effects of piroxicam are rash, headaches, dizziness, drowsiness, abdominal pain, nausea,
constipation, fluid retention, ringing in the ears, and photosensitivity. NSAIDs reduce the ability of blood to clot and
therefore increase bleeding after an injury. Piroxicam also may cause stomach and intestinal bleeding and ulcers.
Sometimes, stomach ulceration and intestinal bleeding can occur without any abdominal pain. Black tarry stools,
weakness, and dizziness upon standing may be the only signs of bleeding. People who are allergic to other
NSAIDs should not use piroxicam. NSAIDs reduce the flow of blood to the kidneys and impair their function of the kidneys.
The impairment is most likely to occur in patients with preexisting impairment of kidney function or congestive heart
failure, and the use of NSAIDs in these patients should be done cautiously. Individuals with asthma are more likely to
experience allergic reactions to piroxicam and other NSAIDs. Fluid retention, blood clots, heart attacks, hypertension,
and heart failure have also been associated with the use of NSAIDs.


USP Standard API Piroxicam Raw Material Powder Piroxicam CAS36322-90-4USP Standard API Piroxicam Raw Material Powder Piroxicam CAS36322-90-4

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Diamond Member Since 2019

Suppliers with verified business licenses

Rating: 4.9/5
Terms of Payment
LC, T/T, D/P, PayPal, Western Union, Small-amount payment
International Commercial Terms(Incoterms)
FOB, CFR, CIF, DAT, FAS, DDP, DAP, CIP, CPT, FCA, EXW, Others